Eli Lilly $5B Pharmaceutical Manufacturing Facility
One of 10,000+ projects Taiyo tracks in Virginia.
Source: REBusinessOnline
Eli Lilly plans to build a $5 billion pharmaceutical manufacturing facility in Goochland County, Virginia, west of Richmond. This will be the company's first fully integrated active pharmaceutical ingredient and drug product facility for its bioconjugate platform and monoclonal antibody portfolio, used for cancer and autoimmune disease treatments. The project will create over 650 permanent jobs an
- Status
- Prospective
- Sector
- Education, Manufacturing (Industrial)
- Location
- Goochland County, Virginia, United States of America
- Updated
- 22 Jul 2026
- Source
- REBusinessOnline
ConstructChat
Ask ConstructChat about Eli Lilly $5B Pharmaceutical Manufacturing Facility
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Eli Lilly plans to build a $5 billion pharmaceutical manufacturing facility in Goochland County, Virginia, west of Richmond. This will be the company's first fully integrated active pharmaceutical ingredient and drug product facility for its bioconjugate platform and monoclonal antibody portfolio, used for cancer and autoimmune disease treatments. The project will create over 650 permanent jobs and 1,800 construction jobs, with completion scheduled within five years. The facility will incorporate advanced technologies such as machine learning, AI, and automated systems, with partnerships planned with local universities. |
Original sector | Life Sciences |
Budget |
Location
Country | United States of America (USA) |
State | Virginia |
City | Goochland County |
Source
Source | REBusinessOnline |
URL |
More Details
Record type | Project |
Sector | Education, Manufacturing (Industrial) |
Article published date | 2025-09-21 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
